1类创新药再“+1”!浦东创新药企迎来新进展

浦东发布
Dec 26, 2025

近日,浦东获批上市的1类创新药名单再次更新,和誉医药首个自研新药贝捷迈获批上市。作为上海生物医药产业的核心承载区,2025年浦东新区已新增9款1类创新药,覆盖肿瘤、代谢疾病、罕见病、心血管等多个临床急需领域。此外,还有许多生物医药企业迎来新进展:畅德医疗自主研发的EF-Yangtze药物洗脱膝下球囊扩张导管近日获批上市,君实生物、来凯医药和拓界生物也在各自研发药物的临床试验中迎来突破。深耕这片...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10